High‐dose‐rate versus low‐dose‐rate intracavitary therapy for carcinoma of the uterine cervix

Abstract

The pelvic control or actuarial complication rates were comparable between HDR and LDR treatment. The difference between the disease specific survival rates for HDR and LDR was not statistically significant for Stage II or III, although in Stage II, patients treated with LDR appeared to have a better survival rate than those treated with HDR.